Table 1. Baseline Patient Characteristics for Patients† Initiating Antiretroviral Treatment in the Botswana National HIV/AIDS Treatment Program, 2002–2013.
| Continuous Variables | Mean | Std. Dev. | Median | IQR |
|---|---|---|---|---|
| Number of Clinic Visits | 10.7 | 8.2 | 9 | 4–15 |
| Months of Follow-up | 48.7 | 39.1 | 40 | 15–79 |
| Age | 36.3 | 9.1 | 35 | 29–42 |
| Baseline CD4 | 150.6 | 117.1 | 139 | 75–191 |
| Indicator Variables | No. of Patients | % of study population | ||
| Women | 61,173 | 63 | ||
| Year of Initiation | ||||
| 2002–2007 | 66,602 | 68 | ||
| 2008–2013 | 31,025 | 32 | ||
| First-line ART regimen (NNRTI or PI) | ||||
| Nevirapine | 38,442 | 39 | ||
| Efavirenz | 53,074 | 54 | ||
| Lopinavir | 6,111 | 6 | ||
| First-line ART regimen (NRTI) | ||||
| Zidovudine | 62,508 | 64 | ||
| Stavudine | 7,196 | 7 | ||
| Tenofovir | 27,923 | 29 | ||
†Table 1 reports on the 97,627 patients included in the regression model.